Skip to content
Home » Availability of generic HIV PrEP drugs highlights financial instability in virus prevention

Availability of generic HIV PrEP drugs highlights financial instability in virus prevention

  • by

[ad_1]

Availability of generic HIV PrEP drugs highlights financial instability in virus prevention – CBS News


Watch CBSN Live



An increased number of pre-exposure prophylaxis, or PrEp drugs, are coming to the market to help lower the cost of for patients. However, the lower-cost options are raising questions over a drug pricing program known as 340B, that generates revenue for critical HIV care and resources. Dr. David Rosenthal, the medical director at the Center for Young Adult, Adolescent and Pediatric HIV at Northwell Health Great Neck New York, joins CBSN’s Lana Zak with his analysis.

Be the first to know

Get browser notifications for breaking news, live events, and exclusive reporting.


[ad_2]

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *